You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 55 No. 5, May 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (22)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Cerebrovascular Disease
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Reversible Segmental Cerebral Arterial Vasospasm and Cerebral Infarction

Possible Association With Excessive Use of Sumatriptan and Midrin

James F. Meschia, MD; Marc D. Malkoff, MD; José Biller, MD

Arch Neurol. 1998;55:712-714.

Objective  To describe a patient who developed reversible segmental cerebral arterial vasospasm and cerebral infarction while taking excessive amounts of sumatriptan succinate and a combination drug (Midrin) consisting of isometheptene mucate, 65 mg, dichloralphenazone, 100 mg, and acetaminophen, 325 mg.

Design  Case report.

Setting  Tertiary care center.

Patient  A 43-year-old man who developed a left occipital infarct after taking a total of 23 sumatriptan succinate tablets (25 mg per tablet) and 32 Midrin tablets during a 7-day period and who on digital subtraction angiography was shown to have segmental cerebral arterial narrowing in multiple vessels. An extensive evaluation for other possible risk factors for cerebral infarction was unrevealing.

Main Outcome and Results  Discontinuation of sumatriptan and Midrin regimens and administration of nicardipine hydrochloride led to nearly total resolution of the angiographic findings, and the patient had no recurrent strokes.

Conclusions  One should consider the diagnosis of drug-induced vasospasm in patients with cerebral infarction and a history of excessive use of sumatriptan and Midrin. The initial angiographic abnormalities may resemble those found in patients with primary angiitis of the central nervous system.


From the Department of Neurology, Mayo Clinic Jacksonville, Jacksonville, Fla (Dr Meschia); and the Indiana University School of Medicine, Indianapolis (Drs Malkoff and Biller).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Call-Fleming syndrome associated with subarachnoid haemorrhage: three new cases
Moustafa et al.
BMJ Case Reports 2009;2009:bcr0920080989-bcr0920080989.
ABSTRACT | FULL TEXT  

Retinal nerve fibre layer thickness measurements using optical coherence tomography in migraine patients
Martinez et al.
Br J Ophthalmol 2008;92:1069-1075.
ABSTRACT | FULL TEXT  

Call-Fleming syndrome associated with subarachnoid haemorrhage: three new cases
Moustafa et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:602-605.
ABSTRACT | FULL TEXT  

The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients
Ducros et al.
Brain 2007;130:3091-3101.
ABSTRACT | FULL TEXT  

Recurrent primary thunderclap headache and benign CNS angiopathy: Spectra of the same disorder?
Chen et al.
Neurology 2006;67:2164-2169.
ABSTRACT | FULL TEXT  

Diffuse cerebral vasoconstriction (Call-Fleming syndrome) and stroke associated with antidepressants.
Noskin et al.
Neurology 2006;67:159-160.
ABSTRACT | FULL TEXT  

Cerebral vasoconstriction and stroke after use of serotonergic drugs
Singhal et al.
Neurology 2002;58:130-133.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.